TNSN98049A1 - Composition pharmaceutique a residence gastrique. - Google Patents
Composition pharmaceutique a residence gastrique.Info
- Publication number
- TNSN98049A1 TNSN98049A1 TNTNSN98049A TNSN98049A TNSN98049A1 TN SN98049 A1 TNSN98049 A1 TN SN98049A1 TN TNSN98049 A TNTNSN98049 A TN TNSN98049A TN SN98049 A TNSN98049 A TN SN98049A TN SN98049 A1 TNSN98049 A1 TN SN98049A1
- Authority
- TN
- Tunisia
- Prior art keywords
- pharmaceutical composition
- gastric residence
- carbon dioxide
- benzamide
- generating system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
CETTE COMPOSITION PHARMACEUTIQUE A RESIDENCE GASTRIQUE EST CARACTERISEE EN CE QU'ELLE COMPREND :(a) UN PRINCIPE ACTIF CONSISTANT EN UN BENZAMIDE OU UN SEL DE BENZAMIDE. (b) UN SYSTEME GENERATEUR DE DIOXYDE DE CARBONE, ET (c) UN MOYEN PERMETTANT LA RETENTION PARTIELLE DU DIOXYDE DE CARBONE GENERE PAR LEDIT SYSTEME GENERATEUR DE DIOXYDE DE CARBONE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9704803A FR2762213B1 (fr) | 1997-04-18 | 1997-04-18 | Composition pharmaceutique a retention gastrique |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN98049A1 true TNSN98049A1 (fr) | 2005-03-15 |
Family
ID=9506077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN98049A TNSN98049A1 (fr) | 1997-04-18 | 1998-04-16 | Composition pharmaceutique a residence gastrique. |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0983065A1 (fr) |
JP (1) | JP2001523241A (fr) |
KR (1) | KR20010006353A (fr) |
CN (1) | CN1252720A (fr) |
AR (1) | AR015586A1 (fr) |
AU (1) | AU737634B2 (fr) |
CA (1) | CA2286081A1 (fr) |
FR (1) | FR2762213B1 (fr) |
HU (1) | HUP0002455A3 (fr) |
IL (1) | IL131995A0 (fr) |
JO (1) | JO2017B1 (fr) |
MA (1) | MA26482A1 (fr) |
NO (1) | NO995039L (fr) |
NZ (1) | NZ500288A (fr) |
PE (1) | PE68199A1 (fr) |
PL (1) | PL336273A1 (fr) |
TN (1) | TNSN98049A1 (fr) |
WO (1) | WO1998047506A1 (fr) |
ZA (1) | ZA983258B (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6169094B1 (en) * | 1998-07-14 | 2001-01-02 | Sanofi-Synthelabo | Compositions of (S) (-)-amisulpride |
FR2784583B1 (fr) | 1998-10-16 | 2002-01-25 | Synthelabo | Composition pharmaceutique a residence gastrique et a liberation controlee |
FR2790388B1 (fr) * | 1999-03-04 | 2001-04-13 | Synthelabo | Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption |
EP1245227A1 (fr) | 2001-03-31 | 2002-10-02 | Jagotec Ag | Comprimé pharmaceutique flottant dans l'estomac destiné à la libération programmée du principe actif et procédé pour produire le matériel flottant compris dans le comprimé |
WO2009157711A2 (fr) * | 2008-06-24 | 2009-12-30 | Park Eun-Seok | Comprimé poreux gastro-rétentif et son procédé de préparation |
FR2949061B1 (fr) * | 2009-08-12 | 2013-04-19 | Debregeas Et Associes Pharma | Microgranules flottants |
EP2719376B1 (fr) * | 2012-10-12 | 2015-03-04 | Omya International AG | Formulation de médicament à rétention gastrique et systèmes d'administration et leur procédé de préparation à l'aide de carbonate de calcium fonctionnalisé |
JP2021505595A (ja) | 2017-12-05 | 2021-02-18 | サノビオン ファーマシューティカルズ インクSunovion Pharmaceuticals Inc. | 結晶形およびその製造方法 |
CN118593482A (zh) | 2017-12-05 | 2024-09-06 | 赛诺维信制药公司 | 非外消旋混合物及其用途 |
JP7044649B2 (ja) * | 2018-06-28 | 2022-03-30 | 株式会社ファンケル | 胃内浮遊錠剤 |
MX2021014774A (es) | 2019-06-04 | 2022-02-03 | Sunovion Pharmaceuticals Inc | Formulaciones de liberacion modificada y usos de las mismas. |
WO2023214018A1 (fr) | 2022-05-06 | 2023-11-09 | Galenix Innovations | Composition à libération prolongée gonflable à rétention gastrique |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2415099A1 (fr) * | 1978-01-20 | 1979-08-17 | Ile De France | Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes |
FR2554718B1 (fr) * | 1983-11-14 | 1986-04-04 | Ethypharm Sa | Nouvelles formes galeniques du sulpiride utilisables par voie orale |
FR2556964A1 (fr) * | 1983-12-23 | 1985-06-28 | Ile De France | Nouvelles formes galeniques du sulpiride utilisables par voie orale |
JPS62178518A (ja) * | 1986-01-30 | 1987-08-05 | Toho Yakuhin Kogyo Kk | 新規持続性スルピリド錠剤 |
JPH0776172B2 (ja) * | 1986-04-16 | 1995-08-16 | 藤沢薬品工業株式会社 | マトリツクス錠 |
CA2039742A1 (fr) * | 1990-04-23 | 1991-10-24 | Andrew B. Dennis | Comprimes pour ingredients pharmaceutiques sujets a problemes : composition et mode de preparation |
-
1997
- 1997-04-18 FR FR9704803A patent/FR2762213B1/fr not_active Expired - Fee Related
-
1998
- 1998-04-15 KR KR1019997009438A patent/KR20010006353A/ko not_active Application Discontinuation
- 1998-04-15 CN CN98804269A patent/CN1252720A/zh active Pending
- 1998-04-15 HU HU0002455A patent/HUP0002455A3/hu unknown
- 1998-04-15 AU AU73416/98A patent/AU737634B2/en not_active Ceased
- 1998-04-15 PL PL98336273A patent/PL336273A1/xx unknown
- 1998-04-15 NZ NZ500288A patent/NZ500288A/xx unknown
- 1998-04-15 WO PCT/FR1998/000755 patent/WO1998047506A1/fr not_active Application Discontinuation
- 1998-04-15 EP EP98920623A patent/EP0983065A1/fr not_active Ceased
- 1998-04-15 CA CA002286081A patent/CA2286081A1/fr not_active Abandoned
- 1998-04-15 JP JP54514398A patent/JP2001523241A/ja active Pending
- 1998-04-15 IL IL13199598A patent/IL131995A0/xx unknown
- 1998-04-16 TN TNTNSN98049A patent/TNSN98049A1/fr unknown
- 1998-04-17 MA MA25037A patent/MA26482A1/fr unknown
- 1998-04-17 PE PE1998000281A patent/PE68199A1/es not_active Application Discontinuation
- 1998-04-17 AR ARP980101773A patent/AR015586A1/es unknown
- 1998-04-17 ZA ZA983258A patent/ZA983258B/xx unknown
- 1998-04-18 JO JO19982017A patent/JO2017B1/en active
-
1999
- 1999-10-15 NO NO995039A patent/NO995039L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO995039L (no) | 1999-12-17 |
CN1252720A (zh) | 2000-05-10 |
AU7341698A (en) | 1998-11-13 |
IL131995A0 (en) | 2001-03-19 |
KR20010006353A (ko) | 2001-01-26 |
HUP0002455A3 (en) | 2001-01-29 |
FR2762213B1 (fr) | 1999-05-14 |
AR015586A1 (es) | 2001-05-16 |
WO1998047506A1 (fr) | 1998-10-29 |
MA26482A1 (fr) | 2004-12-20 |
ZA983258B (en) | 1998-10-19 |
CA2286081A1 (fr) | 1998-10-29 |
AU737634B2 (en) | 2001-08-23 |
EP0983065A1 (fr) | 2000-03-08 |
NO995039D0 (no) | 1999-10-15 |
NZ500288A (en) | 2001-03-30 |
FR2762213A1 (fr) | 1998-10-23 |
PE68199A1 (es) | 1999-07-15 |
PL336273A1 (en) | 2000-06-19 |
JP2001523241A (ja) | 2001-11-20 |
JO2017B1 (en) | 1999-05-15 |
HUP0002455A2 (hu) | 2000-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9604803A (pt) | Composição farmacêutica para administração oral | |
ATE293458T1 (de) | Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen | |
TNSN98049A1 (fr) | Composition pharmaceutique a residence gastrique. | |
HUP9803044A2 (hu) | Ibuprofentartalmú készítmény | |
DE69727922D1 (de) | Schnell zerfallende orale dosierungsform | |
HUP9900560A2 (hu) | PPAR-alfa és PPAR-gamma antagonisták alkalmazása X-szindróma kezelésében | |
UA41346C2 (uk) | Фармацевтична композиція, яка містить флуоксетин або його сіль, таблетка на її основі, спосіб виробництва таблетки, яка диспергується | |
EA200000718A1 (ru) | Композиции целекоксиба | |
RS49523B (sr) | Vodeni farmaceutski rastvor | |
ATE424810T1 (de) | Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung | |
EA200001010A1 (ru) | Применение дексмедетомидина для седативного воздействия в отделении интенсивной терапии | |
BG60101B2 (bg) | Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол | |
NO944214D0 (no) | Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister | |
DE3875611D1 (de) | Pharmazeutische zusammensetzungen. | |
IT1291278B1 (it) | Preparazione farmaceutica a base di nimesulide per uso topico | |
ES2059633T3 (es) | 2-terc.-butil-4-cloro-5-(4-terc.-butilbenciltio)-3(2h)-piridazinona para la lucha contra los moluscos. | |
BG90414A (bg) | 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им | |
DK0669826T3 (da) | (-)-Metrifonatholdigt lægemiddel | |
DE69220229D1 (de) | Somatotropin zur erhoehung der reproduktiven leistung in rinder | |
ATE74505T1 (de) | Schmerzpraeparat. | |
DE69834811D1 (de) | Pelargonsäurevanillylamid enthaltendes tränengas | |
FR2715849B1 (fr) | Forme d'administration solide à délitescence rapide d'un principe actif. | |
RU95119067A (ru) | Способ стимуляции половой функции крупного рогатого скота | |
UA26886C2 (uk) | Солі 1,3-діарил-4,5-поліметилеhімідазолію, що виявляють аhальгезуючу активhість | |
SU1744810A1 (ru) | Вазоактивное средство, нормализующее функции вегетативной нервной системы "димефосфон" |